Shopping Cart
- Remove All
- Your shopping cart is currently empty
AMG-548 is an orally active and selective p38α inhibitor (Ki=0.5 nM), shows slightly selective over p38β (Ki=36 nM) and >1000 fold selective against p38γ and p38δ and is also extremely potent in the inhibition of whole blood LPS stimulated TNFα (IC50=3 nM)[1]. AMG-548 inhibits Wnt signaling by directly inhibiting Casein kinase 1 isoforms δ and ε[2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $126 | 35 days | |
25 mg | $297 | 35 days | |
100 mg | $1,150 | 35 days |
Description | AMG-548 is an orally active and selective p38α inhibitor (Ki=0.5 nM), shows slightly selective over p38β (Ki=36 nM) and >1000 fold selective against p38γ and p38δ and is also extremely potent in the inhibition of whole blood LPS stimulated TNFα (IC50=3 nM |
Targets&IC50 | p38α:0.5 nM (ki), JNK1:11480 nM (ki), JNK2:39 nM (ki), p38α (dog):5.0 nM (ki), p38β:3.6 nM (ki), JNK3:61 nM (ki), CK1:, p38γ:4100 nM (ki), p38δ:2600 nM (ki) |
In vitro | AMG-548 (10 μM) inhibits the hDvl2 shift[2]. AMG-548 is extremely potent in the inhibition of whole blood LPS stimulated TNFa (IC50=3 nM) and IL1b (IC50=7 nM) as well as TNFa induced IL-8 (IC50=0.7 nM) and IL-1b induced IL-6 (IC5050=1.3 nM) in human whole blood[1]. AMG-548 shows >1000 fold selective against p38γ (Ki=2600 nM) and p38δ (ki=4100 nM). AMG-548 has an modest selectivity against JNK2 (ki=39 nM) and JNK3 (ki=61 nM). |
In vivo | The t1/2 is 4.6 hours in rats and 7.3 hours in dogs[1]. AMG-548 has rat F of 62% and dog F of 47%. |
Molecular Weight | 461.56 |
Formula | C29H27N5O |
Cas No. | 864249-60-5 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.